Opera (NASDAQ:OPRA – Get Free Report) is projected to post its Q1 2025 quarterly earnings results before the market opens on Monday, April 28th. Analysts expect Opera to post earnings of $0.26 per share and revenue of $132.48 million for the quarter.
Opera Price Performance
OPRA opened at $15.53 on Friday. The firm has a market cap of $1.37 billion, a PE ratio of 7.88 and a beta of 0.96. The stock has a 50-day moving average price of $16.65 and a 200-day moving average price of $17.86. Opera has a 1 year low of $10.11 and a 1 year high of $22.50. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.10 and a quick ratio of 2.10.
Wall Street Analysts Forecast Growth
OPRA has been the subject of a number of research analyst reports. Piper Sandler assumed coverage on shares of Opera in a research note on Wednesday, February 5th. They issued an “overweight” rating and a $25.00 price target for the company. The Goldman Sachs Group decreased their target price on Opera from $26.00 to $22.50 and set a “buy” rating on the stock in a research note on Monday, April 14th. Five research analysts have rated the stock with a buy rating, According to MarketBeat.com, the company has an average rating of “Buy” and an average price target of $24.70.
Opera Company Profile
Opera Limited, together with its subsidiaries, provides mobile and PC web browsers and related products and services in Norway and internationally. The company offers mobile browser products, such as Opera Mini, Opera browser for Android and iOS, and Opera GX for PCs and Mobile; Opera Touch; PC browsers, including Opera for Computers and Opera GX; Apex Football; Opera VPN Pro; and Opera News, an AI-powered personalized news discovery and aggregation service.
Featured Stories
- Five stocks we like better than Opera
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Short Sellers Gave Up on These 3 Names Recently
- 3 Healthcare Dividend Stocks to Buy
- 3 Boring Stocks Outperforming the Market This Year
- ETF Screener: Uses and Step-by-Step Guide
- If You Wanted To Buy AbbVie and Didn’t, There’s Still Time To Buy
Receive News & Ratings for Opera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Opera and related companies with MarketBeat.com's FREE daily email newsletter.